Orthofix Medical Inc. OFIX

Latest FY: 2025 Healthcare Medical Devices
Market Price $8.69
Market Cap $351.26M
P/E Ratio N/A
Quick Peer Compare (Healthcare):
Revenue (FY 2025) ↑2.9% YoY
$822.31M
3-Yr CAGR: 21.3%
Net Income ↑26.8% YoY
-$92.19M
Net Margin: -11.2%
Free Cash Flow ↑85.9% YoY
-$1.28M
FCF Yield: -0.36%
EPS (Diluted) ↑29.4% YoY
$-2.33
Basic: $-2.33
Return on Equity Efficiency
-20.5%
ROA: -10.8%

📊 Multi-Year Historical Performance & Trends

Financial Performance History Revenue, Net Income & Free Cash Flow
Margins Trend (%) Gross, Operating & Net Margins
Balance Sheet Strength Cash, Debt & Equity
Cash Flow Generation Operating Cash Flow vs CapEx vs FCF

📈 Year-over-Year (YoY) Growth History (OFIX)

All monetary values in millions ($M)
Fiscal Year Revenue Revenue YoY Gross Profit Net Income Net Inc YoY Diluted EPS EPS YoY Div / Sh Div Yield Op. Cash Flow Free Cash Flow FCF YoY
FY 2016 $409.8M $321.9M $3.1M $0.17 0.00% $44.7M $28.3M
FY 2017 $433.8M +5.9% $340.8M $6.2M +103.6% $0.34 +100.0% 0.00% $53.3M $38.7M +36.8%
FY 2018 $453.0M +4.4% $356.4M $13.8M +121.9% $0.72 +111.8% 0.00% $49.9M $36.3M -6.1%
FY 2019 $460.0M +1.5% $359.3M $-28.5M -306.1% $-1.51 -309.7% 0.00% $32.0M $13.0M -64.1%
FY 2020 $406.6M -11.6% $304.7M $2.5M +108.8% $0.13 +108.6% 0.00% $74.3M $58.8M +351.0%
FY 2021 $464.5M +14.2% $349.6M $-38.4M -1,624.8% $-1.95 -1,600.0% 0.00% $18.5M $0.7M -98.8%
FY 2022 $460.7M -0.8% $337.2M $-19.7M +48.5% $-0.98 +49.7% 0.00% $-11.5M $-32.9M -4,868.4%
FY 2023 $746.6M +62.1% $486.3M $-151.4M -666.6% $-4.12 -320.4% 0.00% $-45.8M $-106.0M -222.2%
FY 2024 $799.5M +7.1% $545.9M $-126.0M +16.8% $-3.30 +19.9% 0.00% $25.8M $-9.1M +91.4%
FY 2025 $822.3M +2.9% $566.0M $-92.2M +26.8% $-2.33 +29.4% 0.00% $33.3M $-1.3M +85.9%
$

Valuation

Market Price $8.69
Market Cap $351.26M
Enterprise Value $426.63M
P/E Ratio N/A
P/B Ratio 0.78
FCF Yield -0.36%
Dividend Yield N/A
Shares Outstanding 40,421,700
%

Profitability & Margins

Gross Margin 68.83%
Operating Margin -9.90%
Net Margin -11.21%
Return on Equity (ROE) -20.49%
Return on Assets (ROA) -10.84%
Asset Turnover 0.97x
Revenue 3-Yr CAGR 21.30%
🛡️

Financial Health & Liquidity

Current Ratio 2.45
Cash Ratio 0.48
Debt / Equity 0.350
Debt / Assets 0.185
Cash & Equivalents $82.03M
Total Debt $157.39M
Book Value / Share $11.13
💧

Cash Flow Efficiency

Operating Cash Flow $33.35M
Capital Expenditures (CapEx) $34.63M
Free Cash Flow -$1.28M
OCF / Revenue 4.06%
FCF / Revenue -0.16%
FCF 3-Yr CAGR N/A
🏷️

Per Share Metrics

EPS (Diluted) $-2.33
EPS (Basic) $-2.33
Dividends / Share N/A
Book Value / Share $11.13
EPS YoY Growth 29.39%
🏛️

Balance Sheet (FY 2025)

Total Assets $850.65M
Total Liabilities $400.61M
Stockholders' Equity $450.04M
Current Assets $416.85M
Current Liabilities $170.48M